Apixaban

05/03/2021

We are pleased to announce that the DCP Marketing Authorization related to Medichem Apixaban 5 mg and 2.5 mg film-coated tablets was granted on February 8th, 2021.

Outstanding teamwork from our regulatory, intellectual property, manufacturing and business development departments based in Malta and Spain!

For more information, contact product@medichem.es